Deciphering Obesity Management Guidelines

Slides:

Advertisements

Similar presentations

1 Prediabetes Screening and Monitoring. 2 Prediabetes Epidemiologic evidence suggests that the complications of T2DM begin early in the progression from.

Advertisements

Diabetes in Pregnancy Screening.

Screening for Prediabetes Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention.

Diabetes Mellitus Type 2

The Great Diabetes Epidemic: A Manifesto for Action.

1 Prediabetes Burden. 2 Epidemiology: Health Performance Gaps Prevalence Risk factors –Metabolic syndrome –Obesity Clinical risks of prediabetes –Progression.

Prediabetes Burden.

Insulin Resistance Progression to Diabetes. Hypertension: BP >140/90 Dyslipidemia: ◦TG >150 mg/dL (1.7 mmol.L) ◦HDL-C

 2010 Cengage-Wadsworth Preventing Cardiovascular Disease Chapter 11.

Distribution of metabolic syndrome (MS) components by age and gender Zhao D, et al. Am J Cardiol 2007;100:835– 839.

Getting to goal in Diabetes: reviewing the 2016 ADA standards of care Internal Medicine Grand Rounds 2/2/2016 Omar A. Vargas, MD FACP Associate Professor.

2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults by Michael D. Jensen, Donna H. Ryan, Caroline M. Apovian, Jamy D. Ard,

Case-Based Examination of Treatment Options in Type 2 Diabetes Management.

Diabetic Dyslipidemia in Practice

Updates and Perspectives in Diabetic Dyslipidemia

COPD by the Guidelines.

Statin Selection in the Elderly

NOACs for Cancer-Associated Thrombosis:

Making the Case for Metabolic Surgery in Patients With Obesity and T2DM.

Starting Strong: Initial Evaluation of the Patient With HCV

Essential Updates in Atopic Dermatitis:

The role of metabolic surgery in the management of obesity and t2dm

SGLT2 Inhibitors: What Do the Data Mean for My Patients?

Overview of Disparities

Updates on Obesity Treatment:

Patient Case Discussions in T2D: What Intensification Plan Is Best?

Achieving and Maintaining Weight Loss in Obesity: Clinical Evidence for Novel Approaches.

Obesity and Dyslipidemia: How Would You Treat?

Patient Outcomes in Bariatric Surgery: Bridging the Divide to Postoperative Success.

Can Primary Care Physicians Take the Lead in Combating Obesity?

SGLT2 Inhibitors in the Modern Era: Why and Where?

Introduction. Risk Communication With Patients: Your Guide to Resources and Recommendations.

Obesity Management Today:

Goals. Achieving HbA1c Goals: Applying Guidelines to Intensify Therapy in Patients With Diabetes.

Panelists. One Size May Not Fit All: A New Aspirin Option for the High-Risk Patient.

Metabolically Healthy Patients With Obesity

Decision-making in the eRA of Treating to Target

Need to Know! Screening and Diagnosis of Kidney Disease in Diabetes

Time to Take Gout Seriously

Talking to Patients About Diabetes Management

Improving Management of Type 2 Diabetes in Hispanic/Latino Patients

Case Study. Managing Medication and Adherence in SIHD: Partnering With the Patient to Improve Care.

Prediabetes Burden.

Contemporary Issues in Psoriasis Care: A Call to Action

Rheumatoid Arthritis 2015 Guidelines What's New? What's Different?

Managing Depression is a Team Effort:

Improving Appropriate Access to PCSK9 Inhibitors

Goals. Weight Management Goals and Approaches in Patients With Type 2 Diabetes.

When to Start and What to Use

The Road to Quality Improvement in HER2-Positive Breast Cancer

Modern Advances in Glucose Monitoring

Diabetes Pandemic. The Economics of Managing Patients With Diabetes and Coronary Artery Disease: A Payer Perspective.

Managing HF in Primary Care

Typical Patient Presentation

Moving the Goal Post: Multidisciplinary Management of Advanced NSCLC

THE TRUTH ABOUT MODERN OBESITY AGENTS: ARE THEY REALLY SAFE AND EFFECTIVE?

The Rising Crisis of Prediabetes Diagnosis and Management of the Patient With Prediabetes.

Treating Atypical Hemolytic Uremic Syndrome A Case Discussion

Perspective on the Multidisciplinary Management of PAH

A Multidisciplinary Perspective on the Management of Hypoparathyroidism.

Practical Strategies for Getting Patients With Diabetes to Lipid Goal

Saving the Day.

Selecting Treatment Approaches in Hemophilia

Obesity Management.

CHD RISK Glycemia 75g OGTT Time Metabolic Syndrome

Championing Evidence-Based Care in Patients With Acute Low Back Pain

Statin Selection in Patients With Pre-Diabetes: Case Considerations

Clinical Pearls in the Management of Patients With Advanced Non-Small Cell Lung Cancer.

Risk Stratification of Patients With Type 2 Diabetes: An Interpretation of the Latest Treatment Guidelines.

NAFLD and NASH in Europe and Canada

Presentation transcript:

Deciphering Obesity Management Guidelines

Program Goals

Obesity 2: AHA/ACC/TOS Guidelines

Obesity 2: Five Critical Questions

AACE Obesity Algorithm

Overall Management Goals

Obesity as a Disease

Treatment Recommendations in All Guidelines

Prediabetes Algorithm IGF (100-125); IGT (140-199); Metabolic Syndrome (NCEP 2001)

Obesity 2: Recommendation 1

Complications-Centric Model for Care of the Overweight/Obese Patient

Obesity 2: Recommendation 2

Treatment

Glycemic Control: Lorcaserin in Patients With Type 2 Diabetes

Closing Comments

Abbreviations

Abbreviations (cont)

References

References (cont)

References (cont)

References (cont)

References (cont)